Refined By:
Issue Date:
[2020 TO 2021]
Results 1-6 of 6 (Search time: 0.002 seconds).
| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1 | 2021 | Rejoinder to “Causal Mediation of Semicompeting Risks” | YT Huang | BIOMETRICS 77(4), 1170-1174 | | | |
2 | 2021 | Estimating the causal effect of embryo transfer day on clinical in vitro fertilization outcomes using propensity score matching | HC Hsieh; CI Lee; EY Lai; JY Su; YT Huang; WL Zheng; CH Chen; CC Huang; PY Lin; MS Lee; M Liu; YT Huang | BMC PREGNANCY AND CHILDBIRTH 21, 554 | | | |
3 | 2021 | Fibrosis in Patients with Chronic Hepatitis B and Minimally Raised ALT during Tenofovir Therapy – Authors’ reply | YC Hsu; YT Huang ; JT Lin | LANCET INFECTIOUS DISEASES 21(7), 911 | | | |
4 | 2021 | Causal mediation of semicompeting risks | YT Huang | BIOMETRICS 77(4), 1143-1154 | | | |
5 | 2021 | Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective | YC Hsu; CH Tseng; YT Huang ; HI Yang | Seminars in liver disease 41(03), 285-297 | | | |
6 | 2021 | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial | YC Hsu; CY Chen; IW Chang; CY Chang; CY Wu; TY Lee; MS Wu; MJ Bair; JJ Chen; CC Chen; CH Tseng; CM Tai; YT Huang ; WH Ku; LR Mo; JT Lin | LANCET INFECTIOUS DISEASES 21(6), 823-833 | | | |